100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Stribicin 50mg Injection
Mylan Pharmaceuticals Pvt. Ltd. - A Viatris Company
₹2,015
Our Recommendation
Epithra 50mg Injection 1s
134+ trust this
WHO GMP Certified
WHO GMP
Certified
Long Expiry
(>8 Months)
WHO GMP
Certified
Long Expiry
(>8 Months)
Delivery by
Used In
Cancer
Customers also bought
More About Stribicin 50mg Injection
Benefits
In Cancer : Stribicin 50mg Injection helps to treat certain kinds of cancer. It may be used alone or in combination with other medicines to treat cancer in various parts of the body. Stribicin 50mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Side effects of Stribicin Injection The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Stribicin Low blood platelets Nausea Hair loss Absence of menstrual periods Fever Anemia (low number of red blood cells)Diarrhea Weight loss Decreased white blood cell count (neutrophils)Hot flashes Gastrointestinal inflammation Rash Low energy Eye disorder
How to use
How to use Stribicin Injection Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
How Stribicin Injection works Stribicin 50mg Injection is an anti-cancer medication. It works by suppressing the activity of an enzyme (topoisomerase II) involved in DNA multiplication of the breast cancer cells. It also forms harmful chemicals (free radicals) which cause DNA damage. This slows the growth of breast cancer cells and eventually kills them.
Unsafe: Avoid consuming alcohol with Stribicin 50mg Injection as it is deemed unsafe.
Stribicin 50mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Stribicin 50mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Stribicin 50mg Injection may cause side effects which could affect your ability to drive.Stribicin 50mg Injection may cause episodes of nausea and vomiting, which can temporarily lead to an impairment of the ability to drive.
Stribicin 50mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Stribicin 50mg Injection may not be needed in these patients. Doctor consultation is advised.Lower doses may be considered in patients with serum creatinine > 5 mg/d L.
Stribicin 50mg Injection should be used with caution in patients with liver disease. Dose adjustment of Stribicin 50mg Injection may be needed. Doctor consultation is advised.Use of Stribicin 50mg Injection is not recommended in patients with severe liver disease.
Manufacturer Address
Mylan Pharmaceuticals Private Limited , Commercial Operations , Prestige Tech Park,Platina-3, 7th to 12th floor, Prestige Tech Park, Kadubesanahalli, Bangalore -560103
References
Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1715
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 952
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 478-79
Epirubicin hydrochloride. Wedel, Germany: Medac GmbH; 2008 (26 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (27 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
